Local Media Influence on Opting Out From an Exception From Informed Consent Trial
Article Outline
Study objective
News media are used for community education and notification in exception from informed consent clinical trials, yet their effectiveness as an added safeguard in such research remains unknown. We assessed the number of callers requesting opt-out bracelets after each local media report and described the errors and content within each media report.
Methods
We undertook a descriptive analysis of local media trial coverage (newspaper, television, radio, and Web log) and opt-out requests during a 41-month period at a single site participating in an exception from informed consent out-of-hospital trial. Two nontrial investigators independently assessed 41 content-based media variables (including background, trial information, graphics, errors, publication information, and assessment) with a standardized, semiqualitative data collection tool. Major errors were considered serious misrepresentation of the trial purpose or protocol, whereas minor errors included misinformation unlikely to mislead the lay reader about the trial. We plotted the temporal relationship between opt-out bracelet requests and media reports. Descriptive information about the news sources and the trial coverage are presented.
Results
We collected 39 trial-related media reports (33 newspaper, 1 television, 1 radio, and 4 blogs). There were 13 errors in 9 (23%) publications, 7 of which were major and 6 minor. Of 384 requests for 710 bracelets, 310 requests (80%) occurred within 4 days after trial media coverage. Graphic timeline representation of the data suggested a close association between media reports about the trial and requests for opt-out bracelets.
Conclusion
According to results from a single site, local media coverage for an exception from informed consent clinical trial had a substantial portion of errors and appeared closely associated with opt-out requests.
Introduction
Background
Media have been shown to influence public opinion about medical research.1, 2, 3, 4, 5, 6 Several case reports indicate that news media can sway public opinion about health-related controversies7, 8 and media coverage increased public interest about a phase 1 pharmaceutical trial.9 For emergency care research conducted under exception from informed consent regulations, investigators use media to educate the community and to facilitate required public notification.10, 11 However, previous studies have found that only 5% to 8% of the population was aware of an exception from informed consent project ongoing in their community.12, 13
What is already known on this topic
Emergency care research is often conducted under exception from informed consent; thus, investigators use mass media to notify the public and educate potential trial subjects. The accuracy of media reports and their influence on trial participation are unknown.
What question this study addressed
This descriptive study examined media coverage for an out-of-hospital exception from informed consent trial. Media reports were systematically analyzed, and the number of requests to opt out and their temporal relationship to media releases were tracked.
What this study adds to our knowledge
Twenty-three percent of media reports contained errors; 80% of opt-out requests occurred within 4 days of media releases.
How this might change practice
This work provides guidance for investigators organizing public notification for opt-out trials.
Because research subjects cannot consent before enrollment in exception from informed consent trials, many institutional review boards require investigators to offer a mechanism for individuals to prospectively opt out (though this is not required by federal regulations). The opportunity to opt out depends on awareness that the trial is ongoing, which, at our site, was primarily accomplished through local media coverage. For a member of the community, the decision to opt out hinges on knowing that the trial is ongoing, fearing enrollment in the trial, and having the contact information to reach investigators. It is possible that some element of what people read or hear in media reports triggers a reaction strong enough to drive requests to opt out of the trial, though it is also possible that simply knowing about the trial (regardless of the language used) prompts community objection.
Importance
Investigators designing exception from informed consent trials frequently use the media to educate and notify the community about such trials, yet there are few objective data about how such media may influence public behavior. It is possible that the timing, content, and accuracy of trial information conveyed through news media influence public perception about these trials, plus individual behavior (eg, the desire to opt out). Data about whether the media may influence public behavior and the accuracy of media reports about exception from informed consent trials may help guide investigators in communicating with the media.
Goals of This Investigation
In this study, we evaluate local media coverage of an exception from informed consent trial and seek to characterize the media reporting of the study and its temporal relation to requests to opt out of the trial.
Materials and Methods
Study Design
This was a qualitative analysis of all local media coverage for an exception from informed consent out-of-hospital trial at one clinical research site during a 41-month period (September 1, 2004, through January 31, 2008). This period covered the creation of the multisite research consortium (described below), clinical trial design, and community consultation and public notification phases, as well as the first 12 months of trial enrollment. Data collection for this study was stopped after the first 12 months of the trial because the majority of media coverage and opt-out bracelet requests occurred during the pretrial period and the first 6 months after initiation of the study (ie, fewer than 2 bracelet requests per month after the first 6 months of enrollment). All local media coverage about the clinical trial and research consortium was included. National media coverage was included in a secondary analysis, but only as it related to local bracelet requests at the single study site. The institutional review board at Oregon Health and Science University approved this study.
Setting
The Resuscitation Outcomes Consortium is a research network formed to conduct out-of-hospital controlled clinical trials on patients presenting with life-threatening trauma or cardiac arrest.14 Resuscitation Outcomes Consortium clinical trials function under exception from informed consent regulations (21 CFR 50.24). The first Resuscitation Outcomes Consortium study involves the use of hypertonic saline solution (with and without dextran) versus normal saline solution as an early, field-based resuscitation fluid in patients with severe traumatic brain injury or hemorrhagic shock.15 The media analysis was conducted at one of the 10 Resuscitation Outcomes Consortium study sites (Portland, OR/Vancouver, WA) during the Resuscitation Outcomes Consortium hypertonic saline solution and dextran clinical trial. This study site includes all communities served by emergency medical service providers in a 4-county region containing urban, suburban, rural, and frontier areas, with a total population of approximately 1.75 million people.14
At the request of local institutional review boards, the public could request opt-out bracelets for the trial, beginning at the public notification phase (ie, after final institutional review board approval of the study), several months before the trial was initiated. The intent of the bracelet is to prevent enrollment in the trial, should the wearer become eligible. Bracelet availability was mentioned in all press releases after final institutional review board approval of the study, letters to the community (eg, neighborhood associations, city and government officials, community leaders), and the local Portland Resuscitation Outcomes Consortium Web site. Any community member aged 15 years or older (the minimum age for enrollment) within the 4-county study region (ie, Clackamas, Clark, Multnomah, and Washington Counties) could request an opt-out bracelet by calling the study coordinator and providing a US Postal Service mailing address. Callers could request bracelets for themselves and for immediate family members (ie, spouse, or children at least 15 years old). Callers were not permitted to request bracelets for general distribution (eg, to coworkers, neighbors, or other groups).
The opt-out bracelets are adjustable and made of stainless steel, resembling “medical alert” tags. The bracelets are inscribed with the words “no study,” indicating that the wearer does not wish to be enrolled in any out-of-hospital exception from informed consent trial. Although there was only 1 trial being initiated during this period, investigators anticipated future exception from informed consent trials for which the same bracelet could be used. As part of the emergency responder training for the trial, emergency medical services providers were instructed to look specifically for a bracelet before enrolling a patient.
The Oregon Health and Science University News and Publications Department circulated news releases about the research consortium and hypertonic saline solution and dextran trial. All news releases were reviewed for accuracy and were distributed to a commonly used list of 100 reporters and editors in the metropolitan region. Recipients included a broad range of large-distribution newspapers, minority papers, community newspapers and newsletters, and radio and television stations. All 5 news releases were also available to the public at the university's Web site. Reporters were invited to contact investigators through the Oregon Health and Science University News and Publications Department for further inquiry. A press conference was held immediately before initiation of the trial.
All pertinent local newspaper, radio, television, and Internet coverage was collected by the investigators and by Oregon Health and Science University's News and Publications Department throughout the 41-month period. To ensure that they had found every mention of the trial in the news media, this information was corroborated by tracking Oregon Health and Science University's clipping services (private companies that contract with the media department to monitor all audited media publications statewide), Web-based news sites, statewide television service, and radio coverage in the metropolitan region. The single non–English-language article was translated by an independent translator. Media releases were gathered through an exhaustive search with the online archives of news outlets with the highest nationwide distribution (top 15 news sources), local distribution, and a general Internet search engine. Search terms used included “hypertonic saline study,” “trauma trial,” “resuscitation outcomes consortium,” “ROC trial,” “ROC hypertonic saline,” “research without consent,” and “exception from informed consent trial.”
Data Collection and Processing
Investigators developed a standardized media assessment and data abstraction tool for media coverage related to the trial. Coding of media content (described in detail below) was based on a gestalt of phrases and ideas, rather than specific code words.8 The data collection tool was pilot tested by 2 reviewers by using newspaper articles that had been published at another Resuscitation Outcomes Consortium site (San Diego, CA), allowing adjustments to ensure appropriate definitions for each variable, consistency between reviewers, and clarity in the data collection instrument. Each media piece was transcribed and then independently graded by reviewers, neither of whom was directly involved in the Resuscitation Outcomes Consortium network. After comparison of the reviewer assessments and data abstraction, reviewers met to discuss and resolve discrepancies before compiling a final database. A third reviewer mediated final resolutions for discrepancies that could not otherwise be resolved. Mediation was required only in 2 categories: “author's bias/tone” (12 articles mediated) and “degree to which presentation of information was scientific versus editorialized (3 articles mediated).”
Methods of Measurement
Six categories of media content were used, including background, clinical trial, graphics, errors, publication details, and assessment of writing style. Contained within these media content categories were 41 detailed variables (Table 1). Of note, the term author bias as used in this context is distinct from statistical bias. Author bias is used to describe the tone or editorial angle used by the reporter, which may be used either to promote or decry the study topic. Because the written word is subject to interpretation, reviewers were deliberately conservative in assessing author bias; only articles perceived to be unequivocally “biased” either in favor or opposition of the research were categorized as other than “neutral.”
Table 1. Media content variables.
| Variable | Definition |
|---|---|
| Background information (8) | |
| EIC background | The federal rule allowing exception from informed consent research |
| ROC | The structures or goals of the ROC |
| Federal | Federal regulatory bodies, NIH funding, any federal support |
| Ethics | The ethical considerations or unique ethical nature of exception from informed consent research |
| Trauma outcomes | General outcomes of patients with hemorrhagic shock or traumatic brain injury (patients who would be eligible for enrollment in the study) |
| Public health | Use of the words public health |
| Trauma information | Trauma as an important public concern (ie, number of trauma deaths per year) |
| PolyHeme trial | The PolyHeme (Northfield Laboratories, Inc., Evanston, IL) trial that was considered in Portland and enrolled patients in other US cities⁎ |
| Trial information (13) | |
| EIC in this study | The use of the exception from informed consent in this study |
| FDA/federal approval | The FDA or other federal regulatory body approved the study |
| Protocol, objective | Objective description of the study protocol |
| Protocol, editorial | Editorialized description of the study protocol |
| Trial rationale | How the study will contribute to current medical knowledge or advance science |
| Blood substitute | Saline solution would be used in this trial to replace lost blood |
| Experts, opposed | Experts quoted to say they oppose the research |
| Experts, in support | Experts quoted to say they support the research |
| Nonexperts, opposed | Nonexperts (lay persons) quoted to say they oppose the research |
| Nonexperts, in support | Nonexperts (lay persons) quoted to say they support the research |
| Opt-out bracelet | Availability of a bracelet to wear to signify opting out of the study |
| Opt-out number | Contact information for how to obtain a bracelet |
| Opt-out location | Place in the article the opt-out option was first mentioned |
| Graphic content (6) | |
| Graphics | Presence of any graphic associated with a newspaper article |
| Bracelet | Picture of an opt-out bracelet |
| Investigator | Picture of a trial investigator |
| Community member | Picture of a community member |
| Paramedic | Picture of a paramedic (who would enroll patients) |
| Study fluid | Picture of a bag of study fluid |
| Errors (9) | |
| Content error, major | Major error in the content of the study |
| Content error, minor | Minor error in the content of the study |
| Ethics error, major | Major error in the ethics or legality of study |
| Ethics error, minor | Minor error in the ethics of the study |
| Logistic error, major | Major error in the logistics of how study is conducted |
| Logistic error, minor | Minor error in the logistics of how study is conducted |
| Protocol error, major | Major error in the description of the study protocol |
| Protocol error, minor | Minor error in the description of the study protocol |
| Error location | Location of each of above error types within a media report |
| Publication information (3) | |
| Day | Day of the week media report was published or first aired |
| Forum | Type of media report (newspaper, radio, TV, Web, unknown) |
| Length | Length in words of article or transcribed TV or radio script |
| Assessment (2) | |
| Author bias | Author's bias or tone in description of study (strongly opposed, moderately opposed, neutral, moderately in favor, strongly in favor) |
| Editorialization | Degree to which media report gave facts vs editorialization about the research study (mostly facts, both factual and editorialized content, mostly editorialized) |
⁎Northfield Laboratories. Safety and efficacy of PolyHeme in hemorrhagic shock following traumatic injuries beginning in the pre-hospital setting [home page on the Internet]. Northfield Laboratories, July 31st, 2006 [cited June 18, 2008]. Available at: http://clinicaltrials.gov/ct2/show/NCT00076648. |
Errors were categorized as “logistical” (eg, a wrong contact telephone number or incorrect trial start date), “ethical” (eg, error in approval process, legality, or rationale behind exception from informed consent research), “content” (eg, error in the clinical trial study objective, purpose of the study, description of fluid), or “protocol” (eg, error in timing of study, who participates, opt-in versus opt-out). Each type of error was further classified as either “major” (a serious misrepresentation of information, misleading the recipient) or “minor” (error in semantics or wording, leaving recipient unlikely to misinterpret the main intent or mechanics of the study based on the error).
Outcome Measures
The primary outcome was the total number of callers requesting opt-out bracelets during the period. Calls were grouped into weeks (rather than considered daily) for clarity of graphic representation; however, the timing of calls (by day) after the date of specific media coverage was also tracked. We also calculated the total number of opt-out requests (plus total bracelets) occurring up to 4 calendar days after each media report. Four days was chosen a priori to provide a reasonable period during which individuals exposed to a specific media report may call to request a bracelet according to information contained in the report (eg, for calls placed on a Friday, the resulting discussion about opt-out bracelets may not have occurred until the following Monday). This period was supported by 15 months (public notification and initial trial enrollment period) of tracking prospective local media coverage, monitoring the timing and volume of subsequent opt-out calls, and informal interviews with opt-out bracelet requesters. The date recorded for bracelet requests represented the date bracelets were mailed to the caller. A secondary outcome for the study was the number of bracelets requested (each caller may have requested more than 1 bracelet, potentially representing people who would otherwise have been individual callers).
Data Analysis
To describe media content, errors, and timing, all media reports during the 41-month period were included and assessed with descriptive statistics (median, interquartile range, and proportions). The database was maintained with Microsoft Access 2000 (Microsoft Corporation, Redmond, WA) and statistical analyses were performed using SAS (version 9.1; SAS Institute, Inc., Cary, NC).
Results
A total of 39 local media reports were collected during the 41-month period, including 33 (85%) newspapers or newsletters, 4 (10%) Web logs, 1 (3%) television broadcast that aired twice on local news, and 1 (3%) radio announcement that aired 5 times. One additional television report was aired but excluded because no copy was available. Length of media reports ranged from 183 to 2,197 words (median 498).
Most (90%) of the articles mentioned that an exception from informed consent would be used in the study and noted the federal rule allowing for such research (82%), whereas only 64% explained the background information behind these regulations. The ethical considerations involved in doing this type of research were cited in 13% of media reports. The effects of trauma on the individual were discussed more often than the public health implications of the trial (23% versus 5%). Fifteen percent quoted experts in support of or in opposition to the research. Descriptive characteristics of media reports are summarized in Table 2.
Table 2. Content in media reports for the hypertonic saline solution and dextran out-of-hospital clinical trial.
| Variable | Media Reports (n=39) | |
|---|---|---|
| No. | % | |
| Background information | ||
| EIC background | 25 | 64.1% |
| ROC | 20 | 51.3% |
| Federal | 32 | 82.1% |
| Ethics | 13 | 33.3% |
| Trauma outcomes | 9 | 23.1% |
| Public health | 2 | 5.1% |
| Trauma information | 24 | 61.5% |
| PolyHeme trial | 4 | 10.3% |
| Trial information | ||
| EIC in this study | 35 | 89.7% |
| FDA/federal approval | 27 | 69.2% |
| Protocol, objective | 33 | 84.6% |
| Protocol, editorial | 2 | 5.1% |
| Trial rationale | 17 | 43.6% |
| Blood substitute | 11 | 28.2% |
| Experts, opposed | 2 | 5.1% |
| Experts, in support | 4 | 10.3% |
| Nonexperts, opposed | 1 | 2.6% |
| Nonexperts, in support | 0 | 0% |
| Opt-out bracelet | 23 | 59.0% |
| Opt-out number | 20 | 51.3% |
| Graphics | 4 | 10.3% |
| Errors | ||
| Content error, major | 3 | 7.7% |
| Content error, minor | 1 | 2.6% |
| Ethics error, major | 1 | 2.6% |
| Ethics error, minor | 2 | 5.1% |
| Logistic error, major | 0 | 0% |
| Logistic error, minor | 1 | 2.6% |
| Protocol error, major | 3 | 7.7% |
| Protocol error, minor | 2 | 5.1% |
Thirteen errors were found in 9 (23%) publications, including 7 major and 6 minor errors (4 content, 3 ethical, 1 logistic, and 5 protocol). Errors were primarily found in mainstream news sources (ie, major newspapers and a television news broadcast). No errors were found in alternative Internet news sources, smaller distribution papers, or newsletters. Articles with large author bias against the research tended to have more errors. Sample text of errors found in media reports is listed in Table 3.
Table 3. Text or description of media errors, categorized by error type.
| Text or Description of Error | Error Type |
|---|---|
| “Now with the experiment of hypertonic saline, survival rates would be improved for those patients with severe trauma.” | Content, major |
| “So this is a wonderful opportunity for a blood substitute.” | Content, major |
| “The trial research will replace the use of traditional blood.” | Content, major |
| “[The] test will evaluate a new type of saline solution that paramedics give intravenously to badly injured patients in place of highly perishable blood.” | Content, minor |
| “[The university] is about to … pull off yet another public fraud.” | Ethical, major |
| “…waived consent …“ [4 times in article] | Ethical, minor |
| “…waived consent saline study …” | Ethical, minor |
| “…[P]aramedics will chart how trauma patients fare when given a saline solution of a higher concentration than in normal treatments.” | Logistic, minor |
| “You need to get a free medical alert-type bracelet that paramedics are trained to recognize [in order to participate].” | Protocol, major |
| [Graphic of the principal investigator hanging a bag of study fluid in the hospital emergency department] | Protocol, major |
| “…testing unapproved solutions…” | Protocol, major |
| “The study…will test one of 2 intravenously administered solutions…” | Protocol, minor |
During the 16 months that bracelets were available, there were 28 (72% of total) media reports and 384 requests for 710 opt-out bracelets. Three hundred ten (80%) requests for 578 (81%) bracelets were made within 4 days of local media coverage about the trial (although only 16% of the days were within 4 days of a media event). No duplicate names or addresses were given by bracelet requesters. A median of 47 (interquartile range 38 to 106) bracelets were requested up to 4 days after media coverage. The Figure demonstrates media coverage of the trial and bracelet requests over time. Letters to community leaders and neighborhood associations were mailed once during community consultation and once during the public notification phase. Inclusion of the additional national media reports (n=6) did not suggest a relationship between opt-out bracelet requests and national media coverage (data not shown).

Figure.
Local media reports and opt-out bracelet requests for the hypertonic saline and dextran clinical trial, by week.⁎
Limitations
These findings are limited to a single site participating in a multisite research consortium. Consequently, results are based on a modest sample size of local media articles and bracelet requests. In addition, media coverage is frequently triggered by sentinel articles that are picked up by other media outlets, suggesting correlation (clustering) between certain media reports. Such clustering of articles may have also affected opt-out bracelet requests, a possibility that is suggested by the Figure.
Second, because we did not ask callers to identify how they had heard about the trial or what prompted the call, it is possible that some of the apparent associations between the media content and opt-out requests represent surrogate measures of other factors influencing such requests (eg, penetration of trial information through the news media and other sources). We have previously demonstrated associations between socioeconomic factors (eg, individual beliefs, sociodemographic and cultural factors), geospatial location in the study region, and opt-out requests.16 Because this study was not designed to investigate individual views about the trial or exception from informed consent studies in general, prospectively collected data from individuals requesting to opt out of such trials would add substantially to our findings.
Discussion
Our results suggest that the content and timing of media reports for an exception from informed consent trial are associated with requests to opt out of the trial. The findings also demonstrate inaccuracies in such media coverage. Previous research examining health and medicine, as reported in the popular press, has documented a tension between science and news media.1, 7, 17, 18, 19, 20, 21 Specific to research, one author observed the presence of negative media statements and attitudes towards clinical trials.22 The same study found that people who reported unwillingness to participate in medical research cited media “stories” as a common source of concern.22 Others have commented that media reports of new biomedical developments often exaggerate findings and have the potential to mislead the reader.23, 24 To our knowledge, the link between media content, public behavior, and the decision to participate in emergency care research has not been previously demonstrated. These findings should be considered when press releases for future exception from informed consent trials are developed.
We observed that several media reports referenced a recent controversial exception from informed consent study assessing a blood substitute in hemorrhagic shock. A trial of the blood substitute PolyHeme (Northfield Laboratories, Inc., Evanston, IL) was proposed (but not conducted) 2 years earlier in the same region, with negative press and public opposition. Several of the errors in the media coverage for this trial either directly confused the hypertonic saline solution study with PolyHeme25 or could have easily caused the lay reader to recall the PolyHeme trial and opposition to it.26 Media coverage may have intentionally heightened confusion between the controversial blood substitute trial and the current “salt water solution” trial for dramatic effect, to the detriment of public opinion about the actual proposed trial.
The close timing between media coverage for the trial and opt-out requests could be interpreted as an indication that the public was effectively notified of the research, a portion of whom acted on the opportunity to opt out. If some subset of the population will always want to opt out of exception from informed consent trials, then effective community notification (eg, media coverage) should lead to increased opt-out requests. Opt-out requests during community notification processes might be considered one marker of successful community notification (provided the contact information to opt out is included in such notification), with the caveats that some communities may have inherent propensity (or lack thereof) for declining participating in such research, and some research projects may invite more or less public controversy and opposition.
According to the proportion of errors in the media coverage for this trial and selective inclusion of media content, one might also consider media coverage as an inadequate mechanism to notify the community about such research. If this is the case, then reasonable alternatives should be considered, including the development of clear goals for community consultation and public notification processes in these trials.11, 27, 28 Further clarification and development of tangible goals for community consultation and notification in emergency care research may better guide the delivery of trial information to the public. Our findings suggest that current media coverage is not standardized and contains substantial errors, the effect of which is unknown. Alternatives are equally challenging, yet deserve consideration. For example, direct communication (eg, by mail or telephone) with each household before enrollment in the trial may be cost prohibitive and may further restrict the ability to conduct such research, yet creative use of other public media such as advertising or public service announcements may hold possibility.
It is crucial that investigators and reporters strive to present reliable and accurate information about exception from informed consent trials. The public has a right to know about research conducted in their communities, yet it is important to recognize that the content of such media coverage may directly influence public behavior and decisionmaking about participation in emergency care research. As has been previously suggested, the responsibility for good reporting lies not only with journalists but also with the scientific community in communicating with news media.24, 29, 30 Exception from informed consent researchers and funding agencies might consider budgeting for media training as a means of educating investigators interacting with news media and local reporters covering such research about how to effectively and accurately represent these challenging topics to the public.31
Local media reports appeared closely associated with requests to opt out of an exception from informed consent trial in one study region. Media coverage for the trial contained a substantial amount of misinformation, errors, and inaccuracies, although the effect of these factors on opt-out decisions made by community members remains unknown (Figure).
References
- Are we expecting too much from print media? (an analysis of newspaper coverage of the 2002 Canadian healthcare reform debate). Soc Sci Med. 2006;63:89–102
- . The effectiveness of mass communication to change public behavior. Annu Rev Public Health. 2008;29:219–234
- . The influence of plastic surgery “reality TV” on cosmetic surgery patient expectations and decision making. Plast Reconstr Surg. 2007;120:316–324
- Understanding the characteristics of effective mass media campaigns for back pain and methodological challenges in evaluating their effects. Spine. 2008;33:74–80
- Impact of the media on adolescent sexual attitudes and behaviors. Pediatrics. 2005;116:303–326
- . Can mass media influence emergency department visits for stroke?. Stroke. 2007;38:2115–2122
- . Do the print media “hype” genetic research? (a comparison of newspaper stories and peer-reviewed research papers). CMAJ. 2004;170:1399–1407
- . Myriad and the mass media: the covering of a gene patent controversy. Genet Med. 2007;9:850–855
- Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial. J Clin Oncol. 2002;20:3785–3791
- . Ethical and regulatory challenges associated with the exception from informed consent requirements for emergency research: from experimental design to institutional review board approval. Arch Surg. 2006;141:23;1019; discussion 1024
- . Community consultation for emergency exception to informed consent: how much is enough?. Ann Emerg Med. 2008;51:416–419
- Attitudes of emergency department patients and visitors regarding emergency exception from informed consent in resuscitation research, community consultation, and public notification. Acad Emerg Med. 2003;10:352–359
- Exception from informed consent enrollment in emergency medical research: attitudes and awareness. Acad Emerg Med. 2007;14:187–191
- A descriptive analysis of emergency medical service systems participating in the resuscitation outcomes consortium (ROC) network. Prehosp Emerg Care. 2007;11:369–382
- Hypertonic resuscitation: design and implementation of a prehospital intervention trial. J Am Coll Surg. 2008;206:220–232
- A geospatial analysis of persons opting out of an exception from informed consent out-of-hospital clinical trial. Resuscitation. 2009;80:89–95
- . Evaluation of accuracy of health studies reported in mass media. J Am Pharm Assoc. 2005;45:720–725
- Coverage by the news media of the benefits and risks of medications. N Engl J Med. 2000;342:1645–1650
- . Medical researchers and the media (Attitudes toward public dissemination of research). JAMA. 1992;268:999–1003
- Newspaper reporting of the medical literature. J Gen Intern Med. 1995;10:19–24
- Can even minimal news coverage influence consumer health-related behaviour? (a case study of iodized salt sales, Australia). Health Educ Res. 2008;23:543–548
- . Ethical aspects of clinical trials: the attitudes of the public and out-patients. J Intern Med. 1999;245:571–579
- . An uneasy relationship: the tensions between medicine and the media. Lancet. 1996;347:1600–1603
- . Medical scientists and health news reporting: a case of miscommunication. Ann Intern Med. 1997;126:976–982
- . Treatment for trauma will test new fluid. Oregonian. October 18, 2006;B01
- . Some studies bypass consent: trauma victims may be part of a clinical trial without knowing it. Portland Tribune. October 27, 2006;A1
- . Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of the Society for Academic Emergency Medicine. Acad Emerg Med. 2007;14:e27–e29
- The role of community consultation in the ethical conduct of research without consent. Am J Bioeth. 2006;6:33–35
- Helping journalists get it right: a physician's guide to improving health care reporting. J Gen Intern Med. 2003;18:138–145
- . Reporting medical information: effects of press releases and newsworthiness on medical journal articles' visibility in the news media. Prev Med. 2002;35:519–530
- Turning sexual science into news: sex research and the media. J Sex Res. 2007;44:347–358
- ⁎ Plot for total opt-out bracelet requests (rather than phone calls for bracelets) is qualitatively similar to the plot for bracelets (data omitted for clarity).
Provide feedback on this article at the journal's Web site, www.annemergmed.com.
Supervising editor: Kathy J. Rinnert, MD, MPH
Author contributions: MJN, NMD, TS, DZ, and CDN participated in study design. LH was responsible for media communication from trial investigators. DG was in charge of opt-out bracelet distribution and community interaction. MJN and NMD were data abstractors, and TS mediated. MJN and CDN performed the statistical analyses. TS, MD, and CDN are local investigators in the Resuscitation Outcomes Consortium. All authors participated in article planning and writing and approved the final article. MJN and CDN had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. MJN takes responsibility for the paper as a whole.
Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. This publication was made possible with support from the following sources: Oregon Clinical and Translational Research Institute (#UL1 RR024140, the National Center for Research Resources, a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research); and the Resuscitation Outcomes Consortium (ROC) Training Grant (#U01/HL-04-001, National Heart, Lung, and Blood Institute), and the ROC cooperative grants. The ROC is supported by a series of cooperative agreements to 10 regional clinical centers and 1 data coordinating center (5U01 HL077863, HL077881, HL077871 HL077872, HL077866, HL077908, HL077867, HL077885, HL077885, HL077863) from the National Heart, Lung, and Blood Institute, in partnership with the National Institute of Neurological Disorders and Stroke, US Army Medical Research and Material Command, the Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, the Heart and Stroke Foundation of Canada, and the American Heart Association. The ROC Publications Committee reviewed and approved this manuscript.
Publication date: Available online August 13, 2009.
Reprints not available from the authors.
Please see page 2 for the Editor's Capsule Summary of this article.
PII: S0196-0644(09)00606-4
doi:10.1016/j.annemergmed.2009.05.028
© 2008 Published by Elsevier Inc.

